We all have to remember the way pharmaceuticals are marketed in Australia is far different to that in other countries- namely the USA.
In Australia we are lucky to get ads about antihistamines and headache pain relief let alone marketing moderate to major illnesses/ailments.
You.'re very right about the big pharmaceutical companies knowing value when they see it and can't wait for the efficacy results from PD1.
Here is to hoping CF33's success in mice can be replicated in human trials-becuase that's something no one can ignore.
